Valuation Ipsen

Stocks

Market Closed - Euronext Paris 16:55:00 08/10/2026 BST			5-day change	1st Jan Change
141.50 ^EUR	-2.41%		-0.42%	+18.91%

10-08	Tesco cashes in, OPmobility takes a hit
09-25	US FDA approves Mirum's drug for rare bone disorder	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	11,602	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	18.75%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	10,341	9,326	8,476
Change	-	16.81%	12.22%	1.81%	2.28%	12.1%	-9.82%	-9.12%
P/E	10.4x	12.9x	14x	26.7x	22.4x	11.8x	11.9x	12.1x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.32x	1.97x	1.71x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-13.12x	-6.79x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.53x	2.48x	2.38x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.25x	1.99x	1.74x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	5.37x	5.2x	4.72x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	6.2x	6.15x	5.75x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	8.58x	7.59x	6.81x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	11.7%	13.2%	14.7%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	1.08%	1.08%	1.17%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.02	11.91	11.7
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	12.9%	14.1%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,590	4,687	4,879
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,926	1,794	1,796
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,668	1,516	1,475
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,012	1,002	984.1
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,260	-2,275	-3,126
Reference price ²	80.50	100.50	107.90	110.70	119.00	141.50	141.50	141.50
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	12.06x	2.3x	5.48x	1.06%	13.31B
ELI LILLY AND COMPANY	33.76x	12.26x	24.76x	0.58%	1,060B
JOHNSON & JOHNSON	28.75x	6.35x	18.21x	2.07%	623B
ABBVIE INC.	34.38x	7.99x	16.52x	2.56%	480B
MERCK & CO., INC.	103.88x	5.82x	24.82x	2.39%	352B
ROCHE HOLDING AG	19.43x	4.75x	11.8x	2.78%	345B
NOVARTIS AG	20.28x	5.28x	13.08x	3.01%	274B
ASTRAZENECA PLC	20.79x	4.27x	12.2x	2.08%	249B
AMGEN INC.	26.09x	6.8x	12.11x	2.44%	223B
GILEAD SCIENCES, INC.	-44.42x	6.54x	25.48x	2.24%	182B
Average	25.50x	6.24x	16.45x	2.12%	380.13B
Weighted average by Cap.	32.12x	7.82x	19.03x	1.91%